These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 16410809

  • 1. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
    Jonas JB, Spandau UH, Kamppeter BA, Harder B.
    Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
    [Abstract] [Full Text] [Related]

  • 2. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
    Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U, Kamppeter BA.
    Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
    [Abstract] [Full Text] [Related]

  • 3. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B, Sauder G.
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [Abstract] [Full Text] [Related]

  • 4. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
    Lee J, Freeman WR, Azen SP, Chung EJ, Koh HJ.
    Retina; 2007 May; 27(9):1205-13. PubMed ID: 18046226
    [Abstract] [Full Text] [Related]

  • 5. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.
    Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I.
    Eye (Lond); 2005 Feb; 19(2):163-70. PubMed ID: 15218517
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
    Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF.
    Arch Ophthalmol; 2004 Feb; 122(2):218-22. PubMed ID: 14769599
    [Abstract] [Full Text] [Related]

  • 7. Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.
    Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B.
    Ophthalmic Res; 2006 Feb; 38(6):324-8. PubMed ID: 17047404
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.
    Danis RP, Ciulla TA, Pratt LM, Anliker W.
    Retina; 2000 Feb; 20(3):244-50. PubMed ID: 10872928
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration.
    Sutter FK, Kurz-Levin MM, Scherrer M, Barthelmes D, Fleischhauer JC, Helbig H.
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):297-9. PubMed ID: 17458796
    [Abstract] [Full Text] [Related]

  • 10. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L, Allingham RR, Singh I, Stinnett S, Fekrat S.
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H, Ventura AA, Chung JY, Sharma S, Kaiser PK.
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB.
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ, Zaheer I, Karia N.
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [Abstract] [Full Text] [Related]

  • 14. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
    Konstantinidis L, Berguiga M, Beknazar E, Wolfensberger TJ.
    Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
    [Abstract] [Full Text] [Related]

  • 15. Low-power transpupillary thermotherapy combined with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization.
    Zhang X, Zhu X, Wang D, Xu L, Jonas JB.
    Ophthalmic Res; 2007 Sep; 39(4):241-2. PubMed ID: 17622745
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
    Frimpong-Boateng A, Bunse A, Rüfer F, Roider J.
    Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M, Dogan M, Bayraktar Z, Bayraktar S, Acar N, Altan T, Kapran Z, Yilmaz OF.
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [Abstract] [Full Text] [Related]

  • 18. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB, Scott IU, Gloth JM, Green SN, Yarian DL, Wheatley M.
    Retina; 2007 Mar; 27(9):1201-4. PubMed ID: 18046225
    [Abstract] [Full Text] [Related]

  • 19. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV, Nehemy PG, Schachat AP, Nehemy MB.
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [Abstract] [Full Text] [Related]

  • 20. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J, Studnicka J, Rencová E, Korda V, Hejcmanová D.
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.